SEC Info - Goldman Sachs Group Inc, et al. - ‘SC 13G’ on 1/23/20 re: Achillion Pharmaceuticals Inc

SEC Info℠

Home

Help

Please Sign In

Goldman Sachs Group Inc, et al. – ‘SC 13G’ on 1/23/20 re: Achillion Pharmaceuticals Inc

On: Thursday, 1/23/20, at 10:44am ET · Accession #: 769993-20-30 · File #: 5-82163

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/23/20  Goldman Sachs Group Inc           SC 13G                 1:19K  Achillion Pharmaceuticals Inc     Goldman Sachs & Co. LLC
          Goldman Sachs & Co. LLC

Statement of Acquisition of Beneficial Ownership by a Passive Investor — Sch. 13G
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13G      Statement of Acquisition of Beneficial Ownership      11     28K 
                by a Passive Investor --                                         
                13G_AchillionPharmaceuticals

Document Table of Contents

Page	(sequential)	(alphabetic)	↑Top
		Alternative Formats (Word, et al.) Address of Principal Business Office or, if none, Residence: Citizenship: THE GOLDMAN SACHS GROUP, INC. - Delaware GOLDMAN SACHS & CO. LLC - New York CUSIP Number: 00448Q201 Identification and Classification of Members of the Group If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a: Information Name of Issuer: ACHILLION PHARMACEUTICALS, INC Name of Persons Filing: Notice of Dissolution of Group Ownership.* Ownership of Five Percent or Less of a Class Ownership of More than Five Percent on Behalf of Another Person Title of Class of Securities: Common Stock, par value $0.001 per share
1	1st Page – Filing Submission
4	Item 1(a). Name of Issuer: ACHILLION PHARMACEUTICALS, INC
"	Item 2(a). Name of Persons Filing:
"	Item 2(b). Address of Principal Business Office or, if none, Residence:
"	Item 2(c). Citizenship: THE GOLDMAN SACHS GROUP, INC. - Delaware GOLDMAN SACHS & CO. LLC - New York
"	Item 2(d). Title of Class of Securities: Common Stock, par value $0.001 per share
"	Item 2(e). CUSIP Number: 00448Q201
"	Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:
5	Item 4. Ownership.*
"	Item 5. Ownership of Five Percent or Less of a Class
"	Item 6. Ownership of More than Five Percent on Behalf of Another Person
"	Item 8. Identification and Classification of Members of the Group
"	Item 9. Notice of Dissolution of Group
9	Item 7. Information

SC 13G 1st Page of 11 TOC ↑Top Previous Next ↓Bottom Just 1st
 
UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G
 Under the Securities Exchange Act of 1934
(Amendment No. )* 

               ACHILLION PHARMACEUTICALS, INC.
------------------------------------------------------------------------------- 
(Name of Issuer)

        Common Stock, par value $0.001 per share
------------------------------------------------------------------------------- 
(Title of Class of Securities)  

 00448Q201
--------------------------------------------
(CUSIP Number)

   December 31, 2019
------------------------------------------------------------------------------- 
 (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule 
is filed:                                                                       

[X] Rule 13d-1(b)                                                               

[] Rule 13d-1(c)                                                                

[] Rule 13d-1(d)                                                                

*The  remainder of this cover page shall be filled out for a reporting person's 
initial filing on this form with respect to the subject class of securities,    
and for any  subsequent  amendment  containing  information which  would  alter 
the disclosures provided in a prior cover page.                                 

The  information  required in the  remainder  of this  cover page shall  not be 
deemed to be "filed" for the purpose of Section 18 of the  Securities  Exchange 
Act of 1934 ("Act") or otherwise  subject to the liabilities of that section of 
the Act but  shall be  subject  to all other  provisions  of the Act  (however, 
see the Notes).                                                                 

Page 1 of 11    

SC 13G 2nd Page of 11 TOC 1st Previous Next ↓Bottom Just 2nd
-----------------------                                                         
CUSIP No. 00448Q201                   13G                                   
-----------------------                                                         

------------------------------------------------------------------------------  
1.   Name of Reporting Person                                                 
I.R.S. Identification No. of above Person                           

THE GOLDMAN SACHS GROUP, INC.                               

------------------------------------------------------------------------------  
2.   Check the Appropriate Box if a Member of a Group                         

                                                       (a) [_]
                                                       (b) [_]
------------------------------------------------------------------------------  
3.   SEC Use Only                                                             

------------------------------------------------------------------------------  
4.   Citizenship or Place of Organization                                     

Delaware                                                  

------------------------------------------------------------------------------  
5.   Sole Voting Power                

Number of                 0                                           

    Shares        ----------------------------------------------------------
6.   Shared Voting Power              
Beneficially                                                              
7,302,009         
Owned by                                                              
                  ----------------------------------------------------------
Each          7.   Sole Dispositive Power                         

Reporting                  0                                            

    Person        ----------------------------------------------------------
8.   Shared Dispositive Power         
With:                                                             
7,302,009         

------------------------------------------------------------------------------  
9.   Aggregate Amount Beneficially Owned by Each Reporting Person             

7,302,009                                                 

------------------------------------------------------------------------------  
10.   Check if the Aggregate Amount in Row (9) Excludes Certain Shares          

                                                           [_]

------------------------------------------------------------------------------  
11.   Percent of Class Represented by Amount in Row (9)                         

5.2 %                                                     

------------------------------------------------------------------------------  
12.   Type of Reporting Person                                                  

HC-CO                                                     

------------------------------------------------------------------------------  

Page 2 of 11    

SC 13G 3rd Page of 11 TOC 1st Previous Next ↓Bottom Just 3rd
-----------------------                                                         
CUSIP No. 00448Q201                   13G                                   
-----------------------                                                         

------------------------------------------------------------------------------  
1.   Name of Reporting Person                                                 
I.R.S. Identification No. of above Person                           

GOLDMAN SACHS & CO. LLC                                     

------------------------------------------------------------------------------  
2.   Check the Appropriate Box if a Member of a Group                         

                                                       (a) [_]
                                                       (b) [_]
------------------------------------------------------------------------------  
3.   SEC Use Only                                                             

------------------------------------------------------------------------------  
4.   Citizenship or Place of Organization                                     

New York                                                  

------------------------------------------------------------------------------  
5.   Sole Voting Power                

Number of                 0                                           

    Shares        ----------------------------------------------------------
6.   Shared Voting Power              
Beneficially                                                              
7,302,009         
Owned by                                                              
                  ----------------------------------------------------------
Each          7.   Sole Dispositive Power                         

Reporting                  0                                            

    Person        ----------------------------------------------------------
8.   Shared Dispositive Power         
With:                                                             
7,302,009         

------------------------------------------------------------------------------  
9.   Aggregate Amount Beneficially Owned by Each Reporting Person             

7,302,009                                                 

------------------------------------------------------------------------------  
10.   Check if the Aggregate Amount in Row (9) Excludes Certain Shares          

                                                           [_]

------------------------------------------------------------------------------  
11.   Percent of Class Represented by Amount in Row (9)                         

5.2 %                                                     

------------------------------------------------------------------------------  
12.   Type of Reporting Person                                                  

BD-OO-IA                                                  

------------------------------------------------------------------------------  

Page 3 of 11    

SC 13G 4th Page of 11 TOC 1st Previous Next ↓Bottom Just 4th
Item 1(a).         Name of Issuer:                                              
ACHILLION PHARMACEUTICALS, INC.           

Item 1(b).         Address of Issuer's Principal Executive Offices:             
      1777 SENTRY PARKWAY WEST, BUILDING 14, SUITE 200
BLUE BELL, PA 19422                       

Item 2(a).         Name of Persons Filing:                                      

THE GOLDMAN SACHS GROUP, INC.             
GOLDMAN SACHS & CO. LLC                   

Item 2(b).         Address of Principal Business Office or, if none, Residence: 

The Goldman Sachs Group, Inc.             
200 West Street                           
New York, NY 10282                        

Goldman Sachs & Co. LLC                   
200 West Street                           
New York, NY 10282                        

Item 2(c).         Citizenship:                                                 
THE GOLDMAN SACHS GROUP, INC. - Delaware  
GOLDMAN SACHS & CO. LLC - New York        

Item 2(d).         Title of Class of Securities:                                
Common Stock, par value $0.001 per share  

Item 2(e).         CUSIP Number:                                                
00448Q201                                 

Item 3.            If this statement is filed pursuant to Rules 13d-1(b) or     
            13d-2(b) or (c), check whether the person filing is a:

    (a).[X]  Broker or dealer registered under Section 15 of the Act
(15 U.S.C. 78o).                          
   Goldman Sachs & Co. LLC

(b).[_]  Bank as defined in Section 3(a)(6) of the Act      
(15 U.S.C. 78c).                          

        (c).[_]  Insurance company as defined in Section 3(a)(19) of the Act
(15 U.S.C. 78c).                          

 (d).[_]  Investment company registered under Section 8 of the
       Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e).[X]  An investment adviser in accordance with           
Rule 13d-1(b)(1)(ii)(E);                  
   Goldman Sachs & Co. LLC

     (f).[_]  An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F);             

     (g).[X]  A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G);             
         The Goldman Sachs Group, Inc.

    (h).[_]  A savings association as defined in Section 3(b) of the
     Federal Deposit Insurance Act (12 U.S.C. 1813);

     (i).[_]  A church plan that is excluded from the definition of an
      investment company under Section 3(c)(14) of the
       Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j).[_]  A non-U.S. institution in accordance with          
Rule 13d-1(b)(1)(ii)(J);                  

(k).[_]  A group, in accordance with Rule 13d-1(b)(1)(ii)   
(A) through (K).                          

 If filing as a non-U.S. institution in accordance with Rule
 13d-1(b)(1)(ii)(J), please specify the type of institution:

Page 4 of 11      

SC 13G 5th Page of 11 TOC 1st Previous Next ↓Bottom Just 5th
Item 4.            Ownership.*                                                  

(a).     Amount beneficially owned:                         
                  See the response(s) to Item 9 on the attached cover page(s).

(b).     Percent of Class:                                  
                  See the response(s)to Item 11 on the attached cover page(s).

(c).     Number of shares as to which such person has:      

                 (i).    Sole power to vote or to direct  the vote:  See the
                          response(s) to Item 5 on the attached cover page(s).

                  (ii).   Shared power to vote or to direct the vote:  See the
                          response(s) to Item 6 on the attached cover page(s).

                  (iii).  Sole power to  dispose or to direct  the disposition
                          of:  See the response(s) to  Item 7  on the attached
cover page(s).            

                  (iv).   Shared power to dispose or to direct the disposition
                          of:  See the response(s) to  Item 8  on the attached
cover page(s).            

Item 5.            Ownership of Five Percent or Less of a Class.                
Not Applicable        

Item 6.            Ownership of More than Five Percent on Behalf of Another     
Person.                                   

                  Clients  of  the  Reporting  Person(s) have or  may have the
                  right  to  receive or  the power  to  direct the  receipt of
                  dividends from, or the proceeds from the sale of, securities
                  held  in their accounts. Clients known to have such right or
                  power  with   respect  to  more  than 5%  of  the  class  of
  securities to which this report relates are:
NONE                                      

Item 7.            Identification  and  Classification  of the Subsidiary Which 
                  Acquired  the  Security  Being  Reported  on  by the  Parent
Holding Company.                          
See Exhibit (99.2)    

Item 8.            Identification and Classification of Members of the Group.   
Not Applicable        

Item 9.            Notice of Dissolution of Group.                              
Not Applicable        

Item 10.           Certification.                                               
                  By signing below I certify that, to the best of my knowledge
                and belief, the securities referred to above were acquired
                  and are held in the ordinary course of business and were not
              acquired and are not held for the purpose of or with the
                 effect of changing or influencing the control of the issuer
                 of the securities and were not acquired and are not held in
            connection with or as a participant in any transaction
                 having that purpose or effect, other than activities solely
               in connection with a nomination under Section 240.14a-11.

--------------------------                                                      

*In accordance with the Securities and Exchange Commission Release No.      
34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities
beneficially owned by certain operating units (collectively, the "Goldman Sachs 
Reporting Units") of The Goldman Sachs Group, Inc. and its subsidiaries and     
affiliates (collectively, "GSG"). This filing does not reflect securities, if   
any, beneficially owned by any operating units of GSG whose ownership of        
securities is disaggregated from that of the Goldman Sachs Reporting Units in   
accordance with the Release. The Goldman Sachs Reporting Units disclaim         
beneficial ownership of the securities beneficially owned by (i) any client     
accounts with respect to which the Goldman Sachs Reporting Units or their       
employees have voting or investment discretion or both, or with respect to      
which there are limits on their voting or investment authority or both and      
(ii) certain investment entities of which the Goldman Sachs Reporting Units     
act as the general partner, managing general partner or other manager, to the   
extent interests in such entities are held by persons other than the Goldman    
Sachs Reporting Units.                                                          

Page 5 of 11      

SC 13G 6th Page of 11 TOC 1st Previous Next ↓Bottom Just 6th
 SIGNATURE

After reasonable inquiry and to the best of my knowledge
and belief,  I certify that the information set forth in
this statement is true, complete and correct.           

Date:  January 21, 2020,                                                        

THE GOLDMAN SACHS GROUP, INC.                         

By:/s/ Terry Mosher                                   
----------------------------------------            
Name:  Terry Mosher                                   
Title:  Attorney-in-fact                              

GOLDMAN SACHS & CO. LLC                               

By:/s/ Terry Mosher                                   
----------------------------------------            
Name:  Terry Mosher                                   
Title:  Attorney-in-fact                              

Page 6 of 11      

SC 13G 7th Page of 11 TOC 1st Previous Next ↓Bottom Just 7th
 INDEX TO EXHIBITS

Exhibit No.             Exhibit                                                 
-----------             -------                                                 
99.1          Joint Filing Agreement                                        
99.2          Item 7 Information                                            
99.3          Power of Attorney, relating to                                
THE GOLDMAN SACHS GROUP, INC.                   
99.4          Power of Attorney, relating to                                
GOLDMAN SACHS & CO. LLC                         

Page 7 of 11      

SC 13G 8th Page of 11 TOC 1st Previous Next ↓Bottom Just 8th
                                                                  EXHIBIT (99.1)

      JOINT FILING AGREEMENT

   In  accordance  with Rule  13d-1(k)(1)  promulgated  under  the  Securities
Exchange Act of 1934, the  undersigned agree to the joint filing of a Statement 
on Schedule 13G (including  any and all amendments thereto) with respect to the 
Common Stock, par value $0.001 per share, of ACHILLION PHARMACEUTICALS, INC.    
and further agree to the filing of this agreement  as an Exhibit thereto.       
In addition, each party to this Agreement expressly authorizes each other party 
to this Agreement to file on its behalf any and all amendments to such Statement
on Schedule 13G.                                                                

Date:  January 21, 2020,                                                        

THE GOLDMAN SACHS GROUP, INC.                         

By:/s/ Terry Mosher                                   
----------------------------------------            
Name:  Terry Mosher                                   
Title:  Attorney-in-fact                              

GOLDMAN SACHS & CO. LLC                               

By:/s/ Terry Mosher                                   
----------------------------------------            
Name:  Terry Mosher                                   
Title:  Attorney-in-fact                              

Page 8 of 11      

SC 13G 9th Page of 11 TOC 1st Previous Next ↓Bottom Just 9th
                                                                  EXHIBIT (99.2)

  ITEM 7 INFORMATION

    The  securities   being   reported  on  by  The  Goldman  Sachs Group,  Inc.
("GS Group"), as  a parent  holding  company, are owned, or may be  deemed to be
beneficially owned, by Goldman Sachs & Co. LLC ("Goldman  Sachs"), a broker or  
dealer  registered  under  Section  15 of  the  Act and an investment adviser   
registered  under Section 203 of the  Investment  Advisers Act of 1940. Goldman 
Sachs is a subsidiary of GS Group.                                              

Page 9 of 11      

SC 13G 10th Page of 11 TOC 1st Previous Next ↓Bottom Just 10th
                                                                  EXHIBIT (99.3)

POWER OF ATTORNEY     

KNOW ALL PERSONS BY THESE PRESENTS THE GOLDMAN SACHS GROUP, INC.(the "Company") 
does hereby make,constitute and appoint each of Stephanie Snyder, Jerry Li,     
Eddie Arhagba, Abdul Khayum, Terry Mosher, Rachel Fraizer, and Apoorva Iyer     
(and any other employee of The Goldman Sachs Group, Inc. or one of its          
affiliates designated in writing by one of the attorneys-in-fact), acting       
individually, its true and lawful attorney, to execute and deliver in its       
name and on its behalf whether the Company is acting individually or as         
representative of others, any and all filings required to be made by the        
Company under the Securities Exchange Act of 1934, (as amended, the "Act"),     
with respect to securities which may be deemed to be beneficially owned by      
the Company under the Act, giving and granting unto each said attorney-in-fact  
power and authority to act in the premises as fully and to all intents and      
purposes as the Company might or could do if personally present by one of       
its authorized signatories, hereby ratifying and confirming all that said       
attorney-in-fact shall lawfully do or cause to be done by virtue hereof.        

THIS POWER OF ATTORNEY shall remain in full force and effect until              
March 1, 2021 unless earlier revoked by written instrument, or in the event     
am Attorney-in-fact ceases to be an employee of The Goldman Sachs Group, Inc.   
or one of its affiliates or ceases to perform the function in connection with   
which he or she was appointed Attorney-in-fact prior to March 1, 2021, this     
Power of Attorney shall cease to have effect in relation to such Attorney-in-   
fact upon such cessation but shall continue in full force and effect in         
relation to the remaining Attorneys-in-fact. The Company has the unrestricted   
right unilaterally to revoke the Power of Attorney.                             

This Power of Attorney shall be governed by, and construed in accordance with,  
the laws of the State of New York, without regard to rules of conflicts of law. 

This Power of Attorney supersedes the Power of Attorney granted by the Company  
to Eddie Arhagba, Jose Canas, Abdul Khayum, and Jerry Li on June 19, 2018.      

IN WITNESS WHEREOF, the undersigned has duly subscribed these presents as of    
September 26, 2019.                                                             

GOLDMAN SACHS & CO.LLC                                                          

By: /s/  Karen P. Seymour                                                       
____________________________                                                    
Name:  Karen P. Seymour                                                         
Title: Executive Vice President and                                             
General Counsel and Secretary of the Corporation                  

Page 10 of 11     

SC 13G Last Page of 11 TOC 1st Previous Next ↓Bottom Just 11th
                                                                  EXHIBIT (99.4)

POWER OF ATTORNEY     

KNOW ALL PERSONS BY THESE PRESENTS that GOLDMAN SACHS & CO. LLC (the "Company") 
does hereby make, constitute and appoint each of Stephanie Snyder, Jerry Li,    
Eddie Arhagba, Abdul Khayum, Terry Mosher, Rachel Fraizer, and Apoorva Iyer     
acting individually, its true and lawful attorney, (each, an "Attorney-in-fact")
to execute and deliver in its name and on its behalf, whether the Company is    
acting individually or as representative of others, any and all filings required
to be made by the Company pursuant to Rule 13f-1 or Regulation 13D-G under the  
Securities Exchange Act of 1934, (as amended, the "Act"), which may be required 
of the Company with respect to securities which may be deemed to be beneficially
owned by the Company under the Act, giving and granting unto each said          
Attorney-in-fact power and authority to act in the premises as fully and to all 
intents and purposes as the Company might or could do if personally present by  
one of its authorized signatories, hereby ratifying and confirming all that said
Attorney-in-fact shall lawfully do or cause to be done by virtue hereof.        

THIS POWER OF ATTORNEY shall remain in full force and effect until              
March 1, 2021 unless earlier revoked by written instrument, or in the event     
an Attorney-in-fact ceases to be an employee of The Goldman Sachs Group, Inc.   
or one of its affiliates or ceases to perform the function in connection with   
which he or she was appointed Attorney-in-fact prior to March 1, 2021, this     
Power of Attorney shall cease to have effect in relation to such Attorney-in-   
fact upon such cessation but shall continue in full force and effect in         
relation to the remaining Attorneys-in-fact. The Company has the unrestricted   
right unilaterally to revoke the Power of Attorney.                             

This Power of Attorney shall be governed by, and construed in accordance with,  
the laws of the State of New York, without regard to rules of conflicts of law. 

This Power of Attorney supersedes the Power of Attorney granted by the Company  
to Eddie Arhagba, Jose Canas, Abdul Khayum, and Jerry Li on May 15, 2018.       

IN WITNESS WHEREOF, the undersigned has duly subscribed these presents as of    
September 26, 2019                                                              

GOLDMAN SACHS & CO. LLC                                                         

By: /s/  Karen P. Seymour                                                       
____________________________                                                    
Name:  Karen P. Seymour                                                         
Title: Executive Vice President and                                             
General Counsel and Secretary of the Corporation                  

Page 11 of 11

SC 13G	1st Page of 11	TOC	↑Top	Previous	Next	↓Bottom	Just 1st

SC 13G	2nd Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 2nd

SC 13G	3rd Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 3rd

SC 13G	4th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 4th

SC 13G	5th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 5th

SC 13G	6th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 6th

SC 13G	7th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 7th

SC 13G	8th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 8th

SC 13G	9th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 9th

SC 13G	10th Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 10th

SC 13G	Last Page of 11	TOC	1st	Previous	Next	↓Bottom	Just 11th

Dates Referenced Herein and Documents Incorporated by Reference

		Referenced-On Page
This ‘SC 13G’ Filing	Date	First	Last	Other Filings

	3/1/21	10	11
Filed on:	1/23/20			424B2, 8-K, FWP
	1/21/20	6	8	424B2, FWP
	12/31/19	1		424B2, FWP
	9/26/19	10	11	424B2, FWP
	6/19/18	10		4, 424B2, FWP
	5/15/18	11		13F-HR, 424B2, FWP
	1/12/98	5
				List all Filings

↑Top

Filing Submission 0000769993-20-000030 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Goldman Sachs Group Inc, et al. – ‘SC 13G’ on 1/23/20 re: Achillion Pharmaceuticals Inc

On: Thursday, 1/23/20, at 10:44am ET · Accession #: 769993-20-30 · File #: 5-82163

Previous ‘SC 13G’: ‘SC 13G/A’ on 5/10/19 · Next: ‘SC 13G/A’ on 1/24/20 · Latest: ‘SC 13G/A’ on 4/9/24

Statement of Acquisition of Beneficial Ownership by a Passive Investor — Sch. 13GFiling Table of Contents

Document Table of Contents

Dates Referenced Herein and Documents Incorporated by Reference

Statement of Acquisition of Beneficial Ownership by a Passive Investor — Sch. 13G
Filing Table of Contents